Science Sphere

🦷 A postbiotic gummy may help reduce gum bleeding in just six weeks.

Researchers tested whether heat-inactivated bacteria could support gum health in adults with mild gingivitis, the early stage of gum disease where gums become inflamed and bleed more easily.

In a double-blind clinical trial, 116 adults were randomly assigned to take either postbiotic gummies or placebo gummies twice a day for six weeks.

The gummies contained heat-inactivated Lactiplantibacillus pentosus ONRICb0240, meaning the bacteria were no longer alive but still contained bioactive components that may influence inflammation.

Participants were not given special brushing or oral-care instructions, allowing researchers to test the gummies under normal daily conditions.

By the end of the trial, those taking the postbiotic gummies had less gum bleeding and healthier-looking gums than the placebo group.

This does not replace brushing, flossing, or dental care. But it suggests postbiotics may become a simple add-on for early gum health support.

📃 RESEARCH PAPER
📌 Liu et al., “Consuming heat-inactivated Lactiplantibacillus pentosus ONRICb0240-containing postbiotics reduces gingival inflammation: A double-blind randomized clinical trial”, Journal of Periodontology (2026)

🧠 An early clue to Alzheimer’s risk may appear as early as midlife.

A new study suggests that a blood marker linked to Alzheimer’s disease, called pTau181, may already be detectable in meaningful ways by age 45.

Researchers studied 854 members of the long-running Dunedin Study, a New Zealand birth cohort followed for decades. At age 45, people with higher pTau181 levels were more likely to report concerns about memory and thinking.

But the same marker was not linked to measurable cognitive decline, MRI signs of brain damage, or faster biological ageing at that age.

That makes the finding intriguing, but not diagnostic. It does not mean a person with memory worries in midlife has Alzheimer’s disease.

Instead, it suggests that subtle brain-related changes may begin long before dementia is diagnosed — and that midlife could be an important window for future prevention research.

📃 RESEARCH PAPER
📌 Barrett-Young et al., “Plasma pTau181 is associated with subjective cognitive concerns but not objective cognitive decline or structural brain integrity measures in midlife”, GeroScience (2026)

⚖️ Cancer risk may depend not just on weight, but when weight gain happens.

A large Swedish study suggests that body weight across adult life may shape the risk of several cancers in different ways for men and women.

Researchers analyzed 630,022 people who had repeated weight measurements between ages 17 and 60, then tracked cancer diagnoses through 2023.

People with the steepest weight gain had a higher risk of several obesity-related cancers. The strongest links were seen for liver cancer and esophageal adenocarcinoma in men, endometrial cancer in women, and renal cell carcinoma and pituitary tumors in both sexes.

The timing also mattered. In men, earlier weight gain seemed more strongly linked to some cancer risks, while in women, weight gain after age 30 was more strongly linked to hormone-related cancers.

This does not prove weight gain directly caused cancer. The study is observational and still a preprint.

But it suggests cancer prevention may need a life-course view of weight, not just a single BMI measurement.

📃 RESEARCH PAPER
📌 Nilsson et al., “Weight Trajectories and Cancer Risk: A Pooled Cohort Study”, medRxiv (2026)

🎻 Learning music may help the aging brain stay sharper for longer.

Two recent studies suggest that playing an instrument can support brain health in later life.

In one study, older adults who had played music for decades showed more youthful brain activity while trying to understand speech in a noisy environment. Their brains seemed to use more efficient listening networks, rather than over-recruiting extra regions like older non-musicians.

Another study followed adults around age 73 who learned an instrument for four months. Four years later, those who kept practicing showed better verbal working memory and less shrinkage in the right putamen, a brain region involved in movement, learning, and memory.

This does not prove music prevents dementia. But it suggests that sustained musical practice, even later in life, may help preserve brain function and structure.

📃 RESEARCH PAPERS
📌 Zhang et al., “Long-term musical training can protect against age-related upregulation of neural activity in speech-in-noise perception”, PLOS Biology (2025)

📌 Wang et al., “Never too late to start musical instrument training: Effects on working memory and subcortical preservation in healthy older adults across 4 years”, Imaging Neuroscience (2025)

🧬 A gene linked to lower Alzheimer’s risk may help brain cells resist aging.

Scientists have long known that people carrying the APOE2 version of the APOE gene tend to have a lower risk of Alzheimer’s disease than those carrying APOE4, the strongest known genetic risk factor for late-onset Alzheimer’s.

Now, researchers may have found one reason why.

Using human stem-cell-derived neurons engineered to carry APOE2, APOE3, or APOE4, the team found that APOE2 neurons were better at protecting and repairing their DNA.

They also resisted cellular senescence — a damaged, inflammatory state where cells stop functioning properly but do not die.

Similar protective patterns were seen in aged mice carrying the human APOE2 variant.

This does not mean APOE2 prevents Alzheimer’s, or that a treatment is ready. But it suggests that boosting DNA repair or reducing senescent brain cells could become a new direction for Alzheimer’s research.

📃 RESEARCH PAPER
📌 Gerónimo-Olvera et al., “Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons”, Aging Cell (2026)

💉 GLP-1 drugs may do more than support weight loss — they may also affect reproductive health.

Early research suggests semaglutide could improve fertility-related outcomes in females with PMOS, formerly known as PCOS, a hormone and metabolic condition often linked to irregular periods, insulin resistance, obesity, and reduced ovulation.

In a proof-of-concept analysis from the ongoing RESTORE trial, researchers studied participants aged 12 to 35 who lost at least 10% of their body weight while using injectable semaglutide.

They reported earlier-than-expected improvements in reproductive markers, suggesting that better metabolic health may help restore hormonal balance and ovulation.

A separate review presented at ENDO 2026 found that GLP-1 drugs did not appear to harm male reproductive hormones and may improve testosterone and s***m quality in some men with obesity.

These findings are promising, but still early. Larger, longer studies are needed before GLP-1 drugs can be considered fertility treatments.

📃 RESEARCH PAPER
📌 Cree et al., “Weight Loss Associated with Semaglutide Use is Linked to Improved Reproductive Measures in PMOS: a Proof-Of-Concept Analysis”, Fertility and Sterility (2026)

🧠 A common joint-pain supplement may deserve caution in people with dementia.

Glucosamine is widely used for osteoarthritis, but a new study suggests it may interact with a brain process involved in Alzheimer’s disease progression.

Researchers found that Alzheimer’s brains showed increased “hyperglycosylation” — a buildup of sugar-based molecules called glycans that attach to proteins and can disrupt how brain cells communicate.

In Alzheimer’s mouse models, blocking glycan production improved memory-related outcomes, while glucosamine supplementation increased glycan production and worsened memory-related behavior.

The team also analyzed health records from more than 50,000 people with Alzheimer’s-related dementia or mild cognitive impairment. In people already diagnosed with dementia, glucosamine use was linked to a 25% higher mortality risk.

This does not prove glucosamine directly worsens dementia. The human data were observational, and people should not stop or start supplements without medical advice.

📃 RESEARCH PAPER
📌 Hawkinson et al., “Hyperglycosylation is a metabolic driver of Alzheimer’s disease”, Nature Metabolism (2026)

✍️ The way a person writes may reveal subtle signs of cognitive decline.

A new study suggests that handwriting is not just a motor skill. It also depends on memory, attention, language processing, and executive control — the brain’s ability to plan and coordinate actions.

Researchers studied 58 older adults living in care homes, including 38 with cognitive impairment and 20 without it. Participants used a digital pen and tablet to complete simple pen-control tasks, copying tasks, and sentence dictation.

The clearest differences appeared during dictation, which requires the brain to listen, remember, convert sounds into written words, and control hand movement at the same time.

People with cognitive impairment tended to write more slowly, use more strokes, and show less coordinated writing patterns.

This is not a diagnostic test yet. But digital handwriting analysis could one day become a simple, low-cost way to help screen and monitor cognitive decline.

📃 RESEARCH PAPER
📌 Galrinho et al., “Handwriting speed and pen motor control in older adults with and without cognitive impairment”, Frontiers in Human Neuroscience (2026)

🥕 A child’s taste for vegetables may begin before their first bite.

A small new study suggests that exposure to vegetable flavors in the womb may shape how children respond to those foods years later.

Researchers followed 12 children whose mothers had taken carrot or kale capsules during late pregnancy. At age three, the children were presented with the smells of carrot and kale, while researchers recorded their facial reactions.

Children exposed to carrot before birth showed fewer negative reactions to carrot odor. Those exposed to kale showed fewer negative reactions to kale odor, even though kale is usually a bitter smell children may dislike.

This does not prove that eating vegetables during pregnancy will make children love vegetables. The study was very small and tested smell reactions, not actual food choices.

But it suggests that early flavor memories may begin in the womb — and could gently influence food preferences later.

📃 RESEARCH PAPER
📌 Reissland et al., “Do Human Fetuses Form Long-Lasting Chemosensory Memories? Longitudinal Follow-Up From Fetus to Young Child of Facial Responses to Flavor/Odor Stimuli”, Developmental Psychobiology (2026)

👂 One injection helped people born deaf regain hearing within weeks.

A new gene therapy trial has reported striking results in people with a rare inherited form of deafness caused by mutations in the OTOF gene.

This gene helps make otoferlin, a protein needed for inner-ear hair cells to pass sound signals to the brain. When it does not work properly, the ear may detect sound but fail to transmit it normally.

Researchers treated 10 patients aged 1.5 to 23.9 years by delivering a working copy of OTOF directly into the inner ear using an engineered AAV vector.

Most patients began showing hearing improvement within one month. After six months, average hearing thresholds improved from 106 decibels to 52 decibels.

The treatment was well tolerated, with no serious adverse reactions during 6 to 12 months of follow-up.

This is not a treatment for all deafness, and longer follow-up is still needed. But for OTOF-related hearing loss, it is a remarkable step forward.

📃 RESEARCH PAPER
📌 Qi et al., “AAV gene therapy for autosomal recessive deafness 9: a single-arm trial”, Nature Medicine (2025)